Goldman Sachs India on July 23 acquired an additional 0.92 percent stake in specialty chemical maker Rossari Biotech via open market transactions.
It bought 4,81,443 equity shares in the company at Rs 692.17, bulk deals data on the National Stock Exchange showed. The deal was at a premium of Rs 267.17 per share over Rossari Biotech’s issue price.
Earlier, the global financial advisor had bought 1,95,271 equity shares at an issue price of Rs 425 through the anchor book on June 10.
Rossari Biotech had a stellar debut at Rs 669.25 on the NSE, a 57.5 percent premium over its issue price. The counter closed with 74.51 percent gains at Rs 741.65.